More protein while on weight-loss meds in women
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study tests if eating extra protein helps middle-aged women with overweight or obesity who are just starting a GLP-1 medication. You would eat extra protein for a few weeks while staying active as usual.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 30 and 60 years old
- You have overweight or obesity (BMI over 25)
- You have been prescribed a GLP-1 medicine (like Ozempic or Wegovy) and have taken it for less than 4 weeks
- You are willing to keep your current level of physical activity the same
- You are generally healthy and don't have serious medical conditions
- You are willing to eat pork as part of the extra protein group
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a weight-loss medication (GLP-1 receptor agonist) combined with dietary protein to see if it helps protect muscle while losing fat. It is for adults with obesity who are not taking certain other medications or supplements.
This trial tests how protein supplements affect body weight in people who are either normal weight or overweight. The goal is to see if adding protein helps with weight management.
This study looks at whether exercise can help prevent muscle loss in people taking GLP-1 medications (like Wegovy, Ozempic, or Mounjaro) for weight loss. It may help you keep your muscles strong while you lose weight.
This study tests whether adding protein supplements and resistance training (like lifting weights) can help adults 45+ with overweight or obesity get better results from weight-loss medications such as Wegovy or Mounjaro. It looks at changes in body composition, metabolism, and how well your body uses protein.
This trial tests whether adding resistance exercise and extra protein can help you keep your muscle while taking weight loss medications like semaglutide or tirzepatide. It is for people with a BMI of 27 or higher who are not already exercising regularly.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.